Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan vs Adrenaline in CABG Patients With Low LV Function
NCT05222256Completed
- Sponsor
- Assiut University
- Start
- Mar 2022
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of levosimendan in myocardial dysfunction (2 arms), sponsored by Assiut University. Primary endpoint: Systolic function (Ejection Fraction) at 24 hours. Started Mar 2022; status: completed.
02
Drugs
levosimendan
03
Conditions
myocardial dysfunction
Beyond the preview
Go deeper on NCT05222256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05222256.